49.48 USD
-0.36 (-0.72%)
49.48 USD
0 (0%)
COLL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. While COLL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. COLL scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, COLL could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
COLL had positive earnings in the past year.
COLL had a positive operating cash flow in the past year.
Of the past 5 years COLL 4 years were profitable.
In the past 5 years COLL always reported a positive cash flow from operatings.
1.2 Ratios
COLL has a better Return On Assets (3.64%) than 83.77% of its industry peers.
COLL's Return On Equity of 21.27% is amongst the best of the industry. COLL outperforms 91.10% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.10%, COLL belongs to the top of the industry, outperforming 87.96% of the companies in the same industry.
COLL had an Average Return On Invested Capital over the past 3 years of 11.08%. This is in line with the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.64% | ||
| ROE | 21.27% | ||
| ROIC | 9.1% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
With an excellent Profit Margin value of 7.72%, COLL belongs to the best of the industry, outperforming 82.72% of the companies in the same industry.
In the last couple of years the Profit Margin of COLL has declined.
The Operating Margin of COLL (20.74%) is better than 88.48% of its industry peers.
In the last couple of years the Operating Margin of COLL has grown nicely.
Looking at the Gross Margin, with a value of 57.22%, COLL is in the better half of the industry, outperforming 68.06% of the companies in the same industry.
In the last couple of years the Gross Margin of COLL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.74% | ||
| PM (TTM) | 7.72% | ||
| GM | 57.22% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), COLL is creating some value.
Compared to 1 year ago, COLL has less shares outstanding
Compared to 5 years ago, COLL has less shares outstanding
The debt/assets ratio for COLL has been reduced compared to a year ago.
2.2 Solvency
COLL has an Altman-Z score of 1.52. This is a bad value and indicates that COLL is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COLL (1.52) is comparable to the rest of the industry.
COLL has a debt to FCF ratio of 2.79. This is a good value and a sign of high solvency as COLL would need 2.79 years to pay back of all of its debts.
COLL has a better Debt to FCF ratio (2.79) than 90.58% of its industry peers.
A Debt/Equity ratio of 2.71 is on the high side and indicates that COLL has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.71, COLL is doing worse than 81.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 2.79 | ||
| Altman-Z | 1.52 |
ROIC/WACC0.99
WACC9.22%
2.3 Liquidity
COLL has a Current Ratio of 1.36. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
COLL has a Current ratio of 1.36. This is in the lower half of the industry: COLL underperforms 74.35% of its industry peers.
COLL has a Quick Ratio of 1.27. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of COLL (1.27) is worse than 70.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
COLL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.73%, which is quite impressive.
COLL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 154.78% yearly.
Looking at the last year, COLL shows a very strong growth in Revenue. The Revenue has grown by 26.34%.
COLL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.31% yearly.
EPS 1Y (TTM)30.73%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%39.75%
Revenue 1Y (TTM)26.34%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%31.42%
3.2 Future
COLL is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.58% yearly.
The Revenue is expected to grow by 3.62% on average over the next years.
EPS Next Y19.18%
EPS Next 2Y12.57%
EPS Next 3Y-4.69%
EPS Next 5Y-1.58%
Revenue Next Year24.31%
Revenue Next 2Y13.52%
Revenue Next 3Y2.59%
Revenue Next 5Y3.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
COLL is valuated cheaply with a Price/Earnings ratio of 6.88.
Compared to the rest of the industry, the Price/Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 94.24% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.84. COLL is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 6.05 indicates a rather cheap valuation of COLL.
94.24% of the companies in the same industry are more expensive than COLL, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.40, COLL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.88 | ||
| Fwd PE | 6.05 |
4.2 Price Multiples
COLL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. COLL is cheaper than 98.43% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 96.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.41 | ||
| EV/EBITDA | 5.12 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of COLL may justify a higher PE ratio.
COLL's earnings are expected to decrease with -4.69% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y12.57%
EPS Next 3Y-4.69%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
49.48
-0.36 (-0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners120.37%
Inst Owner Change0.64%
Ins Owners1.43%
Ins Owner Change-0.82%
Market Cap1.56B
Revenue(TTM)757.07M
Net Income(TTM)58.44M
Analysts81.82
Price Target49.64 (0.32%)
Short Float %18.91%
Short Ratio11.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.9%
Min EPS beat(2)1.88%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.15%
Min EPS beat(4)1.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)12.99%
EPS beat(12)9
Avg EPS beat(12)-15.06%
EPS beat(16)10
Avg EPS beat(16)-21.97%
Revenue beat(2)2
Avg Revenue beat(2)5.22%
Min Revenue beat(2)1.9%
Max Revenue beat(2)8.53%
Revenue beat(4)3
Avg Revenue beat(4)2.75%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)8.53%
Revenue beat(8)4
Avg Revenue beat(8)0.8%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)8
Avg Revenue beat(16)-3.75%
PT rev (1m)3.99%
PT rev (3m)9.12%
EPS NQ rev (1m)-0.33%
EPS NQ rev (3m)7.88%
EPS NY rev (1m)-15.27%
EPS NY rev (3m)-8.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.69%
Revenue NY rev (1m)4.07%
Revenue NY rev (3m)3.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.88 | ||
| Fwd PE | 6.05 | ||
| P/S | 2.07 | ||
| P/FCF | 5.41 | ||
| P/OCF | 5.38 | ||
| P/B | 5.69 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.12 |
EPS(TTM)7.19
EY14.53%
EPS(NY)8.17
Fwd EY16.52%
FCF(TTM)9.15
FCFY18.5%
OCF(TTM)9.2
OCFY18.6%
SpS23.95
BVpS8.69
TBVpS-18.86
PEG (NY)0.36
PEG (5Y)N/A
Graham Number37.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.64% | ||
| ROE | 21.27% | ||
| ROCE | 13.6% | ||
| ROIC | 9.1% | ||
| ROICexc | 12.09% | ||
| ROICexgc | N/A | ||
| OM | 20.74% | ||
| PM (TTM) | 7.72% | ||
| GM | 57.22% | ||
| FCFM | 38.21% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score7
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 2.79 | ||
| Debt/EBITDA | 1.94 | ||
| Cap/Depr | 0.72% | ||
| Cap/Sales | 0.21% | ||
| Interest Coverage | 2.17 | ||
| Cash Conversion | 75.92% | ||
| Profit Quality | 495.01% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 1.52 |
F-Score7
WACC9.22%
ROIC/WACC0.99
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.73%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%39.75%
EPS Next Y19.18%
EPS Next 2Y12.57%
EPS Next 3Y-4.69%
EPS Next 5Y-1.58%
Revenue 1Y (TTM)26.34%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%31.42%
Revenue Next Year24.31%
Revenue Next 2Y13.52%
Revenue Next 3Y2.59%
Revenue Next 5Y3.62%
EBIT growth 1Y-18.86%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year154.57%
EBIT Next 3Y23.61%
EBIT Next 5Y18.85%
FCF growth 1Y8.55%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y8.67%
OCF growth 3Y25.54%
OCF growth 5Y49.12%
COLLEGIUM PHARMACEUTICAL INC / COLL FAQ
What is the ChartMill fundamental rating of COLLEGIUM PHARMACEUTICAL INC (COLL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to COLL.
Can you provide the valuation status for COLLEGIUM PHARMACEUTICAL INC?
ChartMill assigns a valuation rating of 9 / 10 to COLLEGIUM PHARMACEUTICAL INC (COLL). This can be considered as Undervalued.
What is the profitability of COLL stock?
COLLEGIUM PHARMACEUTICAL INC (COLL) has a profitability rating of 8 / 10.
Can you provide the financial health for COLL stock?
The financial health rating of COLLEGIUM PHARMACEUTICAL INC (COLL) is 5 / 10.